Zealand Pharma A/S (ZLDPF) News Today $108.30 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Zealand Pharma A/S (OTCMKTS:ZLDPF) Releases Quarterly Earnings Results, Beats Expectations By $0.19 EPSZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.78) by $0.19. Zealand Pharma A/S had a negative return on equity of 18.49% and a negative net margin of 1,375.16%.February 21 at 10:59 AM | marketbeat.comZealand Pharma A/S (ZLDPF) Q4 2024 Earnings Call TranscriptFebruary 20 at 4:06 PM | seekingalpha.comZealand Pharma convenes its Annual General Meeting 2025February 20 at 12:23 PM | finance.yahoo.comZealand Pharma A/S (ZLDPF) Projected to Post Quarterly Earnings on TuesdayZealand Pharma A/S (OTCMKTS:ZLDPF) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sees Significant Increase in Short InterestZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 1,588,400 shares, an increase of 28.4% from the January 15th total of 1,237,500 shares. Based on an average trading volume of 2,000 shares, the short-interest ratio is presently 794.2 days.February 14, 2025 | marketbeat.comZealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial resultsFebruary 13, 2025 | globenewswire.comZealand Pharma initiated with an Equal Weight at Morgan StanleyFebruary 12, 2025 | markets.businessinsider.comZealand Pharma downgraded to Hold from Buy at SEB EquitiesJanuary 29, 2025 | markets.businessinsider.comCantor Fitzgerald bullish on Zealand Pharma stock, retains Overweight ratingJanuary 24, 2025 | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Upgraded to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald upgraded Zealand Pharma A/S to a "strong-buy" rating in a report on Tuesday.January 24, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Short Interest Up 39.7% in DecemberZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,166,300 shares, an increase of 39.7% from the December 15th total of 835,100 shares. Based on an average daily trading volume, of 2,100 shares, the short-interest ratio is presently 555.4 days.January 15, 2025 | marketbeat.comZealand Seeks to Usurp Wegovy, Zepbound With Obesity DrugJanuary 13, 2025 | msn.comZealand Seeks to Usurp Wegovy, Zepbound With New Obesity DrugJanuary 13, 2025 | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Stock Price Down 2.5% - Here's WhyZealand Pharma A/S (OTCMKTS:ZLDPF) Shares Down 2.5% - Time to Sell?January 4, 2025 | marketbeat.comZealand Pharma AS ZLDPFDecember 24, 2024 | morningstar.comJefferies Sticks to Its Buy Rating for Zealand Pharma (ZLDPF)December 20, 2024 | markets.businessinsider.comBTIG Remains a Buy on Zealand Pharma (ZLDPF)December 20, 2024 | markets.businessinsider.comZealand Pharma CEO says Novo's CagriSema data supports monotherapy approach to cagrilintideDecember 20, 2024 | reuters.comZealand Pharma Shares Fall After FDA Pushes Back Bowel-Disease DrugDecember 20, 2024 | marketwatch.comFDA rejects Zealand Pharma's drug for short bowel syndromeDecember 19, 2024 | msn.comUS FDA declines to approve Zealand Pharma's bowel disease drugDecember 19, 2024 | reuters.comZealand Pharma announces first participant enrolled in ZUPREME-1December 12, 2024 | markets.businessinsider.comBerenberg Bank Sticks to Their Buy Rating for Zealand Pharma (ZLDPF)December 11, 2024 | markets.businessinsider.comZealand Pharma starts Phase 2b trial for obesity drug candidate petrelintideDecember 10, 2024 | reuters.comZealand Pharma initiated with an Overweight at JPMorganNovember 8, 2024 | markets.businessinsider.comZealand Pharma’s 2024 Progress and Financial ResultsNovember 8, 2024 | markets.businessinsider.comZealand Pharma Announces Financial Results for the First Nine Months of 2024November 7, 2024 | markets.businessinsider.comZealand Pharma to start phase 2b trial for obesity drug candidate in Q4November 7, 2024 | reuters.comZealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial resultsNovember 1, 2024 | globenewswire.comNovo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'October 11, 2024 | msn.comWegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO saysOctober 11, 2024 | cnbc.comZealand Pharma A/S (OTCMKTS:ZLDPF) Trading Down 2.3% - What's Next?Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading Down 2.3% - Here's WhyOctober 10, 2024 | marketbeat.comZealand, Boehringer win FDA breakthrough status to treat fatty liverOctober 8, 2024 | reuters.comZealand Pharma Gets FDA Complete Response Letter for Hypoglycemia New Drug ApplicationOctober 8, 2024 | marketwatch.comUS FDA declines to approve Zealand's drug for low blood sugar in infantsOctober 8, 2024 | msn.comNew Zealand's Fonterra upgrades dividend payout policySeptember 30, 2024 | reuters.comJefferies Sticks to Their Buy Rating for Zealand Pharma (ZLDPF)September 11, 2024 | markets.businessinsider.comZealand Pharma A/S (OTCMKTS:ZLDPF) Trading Up 2%Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading 2% HigherSeptember 7, 2024 | marketbeat.comJefferies Remains a Buy on Zealand Pharma (ZLDPF)August 20, 2024 | markets.businessinsider.comZealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 52-Week High at $141.74Zealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 12-Month High at $141.74August 16, 2024 | marketbeat.comZealand Pharma wants a big partner for its weight loss drugAugust 16, 2024 | msn.comZealand Pharma A-S earnings: here's what to expectAugust 15, 2024 | markets.businessinsider.comZealand Pharma seeks big pharma partners for obesity drug candidateAugust 15, 2024 | reuters.comShort Interest in Zealand Pharma A/S (OTCMKTS:ZLDPF) Rises By 21.4%Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 746,000 shares, an increase of 21.4% from the July 15th total of 614,500 shares. Based on an average trading volume of 2,400 shares, the days-to-cover ratio is currently 310.8 days.August 15, 2024 | marketbeat.comDestiny Pharma initiates research to explore XF drug potential for CFAugust 14, 2024 | markets.businessinsider.comFSD Pharma Rebrands As Quantum BioPharma: Major Share Consolidation AnnouncedAugust 12, 2024 | msn.comZealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial resultsAugust 12, 2024 | globenewswire.comZealand Pharma A/S (22Z.MU)August 3, 2024 | finance.yahoo.comZealand Pharma Appoints Eric Cox as Chief Commercial OfficerJuly 29, 2024 | globenewswire.com4 high-conviction stock picks from top ETF managers — including GMO and a fund up 90% since 2022July 24, 2024 | businessinsider.com Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address ZLDPF Media Mentions By Week ZLDPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLDPF News Sentiment▼0.570.60▲Average Medical News Sentiment ZLDPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLDPF Articles This Week▼51▲ZLDPF Articles Average Week Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News Today TEVA News Today SMMT News Today GMAB News Today GNMSF News Today MRNA News Today ITCI News Today VTRS News Today RDY News Today SRPT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ZLDPF) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
